Lobbying Expenditures and Campaign Contributions by the Pharmaceutical and Health Product Industry in the United States, 1999-2018

JAMA Internal Medicine - United States
doi 10.1001/jamainternmed.2020.0146
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Product Market Competition and Lobbying Coordination in the U.S. Mobile Telecommunications Industry

SSRN Electronic Journal
2004English

Differences in Health Care Resource Utilization and Expenditures Among Schizophrenic Patients in the United States by Health Insurance Status, 2007-2008

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

How the Pharmaceutical Industry Brings an Antibiotic Drug to Market in the United States.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1994English

Intellectual Property and Pharmaceutical Prices in the United States

The Southwest Respiratory and Critical Care Chronicles
2015English

Developing the Latest Framework to Measure and Incentivise Pharmaceutical Industry Contributions to Health Research and Development

Health Research Policy and Systems
MedicineHealth Policy
2018English

Chemical Industry in the United States

Nature
Multidisciplinary
1935English

Typhoid Fever in the United States, 1999-2006

JAMA - Journal of the American Medical Association
Medicine
2009English

Tobacco Industry Lobbying Undermines Public Health in Asia

British Medical Journal
Medicine
2015English

Physics in Industry in the United States

Nature
Multidisciplinary
1935English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy